Back to FEDERATED HERMES, INC. FEDERATED HERMES, INC.

ARCTARCT
Showing 8 of 25 quarters

Position history for FEDERATED HERMES, INC.FEDERATED HERMES, INC.'s holdings in ARCTURUS THERAPEUTICS HLDGS

FEDERATED HERMES, INC. holds 3.3M shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $22.2M as of 2026-Q2. ARCT represents 0.0% of FEDERATED HERMES, INC.'s portfolio.

Current Value

$22.2M

Current Shares

3.3M

Total Value Change

-$86.7M

Total Shares Change

-1.4M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
3.3M
0.0%
$22.2M0.0%$6.72
0
2026-Q1
Unchanged
3.3M
0.0%
$25.5M0.0%$7.91
0
2025-Q4
Decreased
3.3M
-29.6%
$20.3M0.0%$6.19
0
2025-Q3
Unchanged
4.7M
0.0%
$86.5M0.2%$18.78
0
2025-Q2
Unchanged
4.7M
0.0%
$61.1M0.1%$13.33
0
2025-Q1
Unchanged
4.7M
0.0%
$49.7M0.1%$11.58
0
2024-Q4
Unchanged
4.7M
0.0%
$79.7M0.2%$16.58
0
2024-Q3
Unchanged
4.7M
0.0%
$108.9M0.2%$22.03
0

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used